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It has been hypothesized, but not yet proven, that T 
cell dysfunction is operative in the pathogenesis of atopic 
dermatitis. In order to test this hypothesis, we assessed 
different quantitative and functional parameters indic-
ative of T cell reactivity in atopic dermatitis patients 
and, for control purposes, in age-matched normal indi-
viduals. We found that mononuclear cells from atopic 
dermatitis patients proliferated in response to various 
concentrations of the mitogens concanavalin A (Con A) 
and phytohemagglutinin as well as did mononuclear 
cells from controls. However, atopic dermatitis patients, 
regardless of their clinical characteristics, have a sig-
nificant decrease in the relative percentages of circulat-
ing total E rosette forming cells. The reduction in total 
T cell percentages may be due, in part, to a highly 
significant reduction in the percentages of Fc-IgG recep-
tor bearing T cells (Ty cells) that we found in atopic 
dermatitis patients at every level of clinical involvement. 
Fc-IgM receptor bearing T cell values (TIL cells) were 
found to be within the normal range. A defect related to 
the severity of the eczematous eruption was revealed 
when we investigated the capability of Con A-activated 
mononuclear cells from either atopies or normals to 
suppress mitogenic responses of autologous and alloge-
neic mononuclear cells. We found that cells from atopic 
dermatitis patients with wide-spread clinical involve-
ment could not be educated to express suppressor signals 
as effectively as could cells from clinically inactive pa-
tients or normal healthy individuals. Based on these 
findings, we propose that a regulatory cell defect oper-
ating at the T cell level participates in the pathogenesis 
of various aspects of atopic dermatitis. 
In the past few years, considerable attention has focused on 
immunological abnormalities in atopic dermatitis. Apart from 
reports on depressed polymorphonuclear and mononuclear leu-
kocyte chemotaxis and phagocytosis [1-3], there are several 
lines of evidence which point to an impairment of T lymphocyte 
function. Atopic dermatitis patients have an increased fre-
quency and severity of viral and fungal infections [4-7], exhibit 
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impaired delayed-type hypersensitivity reactions towards anti-
gens [2,8,9] and are less easily sensitized to dinitrochloroben-
zene than are other groups of patients [2,10,11). Assuming t hat 
th ese phenomena are indeed attributable to a T lymphocyte 
dysfunction, this defect could reside in either the regulatory or 
the effector T cell pool or in both. Recent evidence indicates 
that a cardinal phenomenon of atopic disease, i.e. hyperimmu-
noglobulinemia E, is attributable to a suppressor cell dysfunc-
tion [12). This study was an attempt to determine whether a 
suppressor cell dysfunction of a broader scope might exist in 
atopic dermatitis patients and might then account for manifes-
tations of atopic dermatitis other than hyperimmunoglobu-
linemia E. For these investigations, we have chosen 2 experi-
mental approaches. 
First, we determined T cell subpopulations in atopic derma-
titis patients and age-matched controls with particular regard 
to their expression of immunoglobulin-receptors since there is 
evidence that T cells capable of suppressing polyclonal B cell 
activation belong to the subpopulation which bears Fc-IgG 
receptors (Ty cells), whereas T cells with Fc-IgM receptors (Tf.L 
cells) seem to provide helper stimuli [13-15). 
Secondly, based on the evidence that concanavalin A (Con 
A) induces the generation of antigen-nonspecific suppressor T 
cells in vitro [16-18], we investigated the ability of Con A-
activated mononuclear cells from either atopic dermatitis pa-
tients or age-match ed nonatopic normal volunteers to suppress 
mitogenic responses in autologous and allogeneic cells. 
Results obtained demonstrate that in atopic dermatitis pa-
tients there is a significant reduction in the number of T cells 
expressing Fc-IgG receptors as compared to normal volunteers 
and that this reduction is independent of disease activity. In 
addition, clinically active atopic dermatitis patients but not 
clinically inactive patients and normals, have a defect in the 
ability to generate antigen-nonspecific suppressor cells. 
MATERIALS AND METHODS 
Study Popula.tion 
Three categories of individuals were included in this study. Group I 
included 11 patients ranging from 9-35 yr of age (mean age: 20.8 ± 2.3 
SEM). These patients had severe generalized atopic eczema which 
spared only few areas of the skin. Five of the It individuals suffe red 
from asthma, allergic rhinitis and eczema; the other 6 had eczema 
alone. 
Group II included 14 patients whose age ranged from 10-66 yr (mean 
age: 24.1 ± 4.0 SEM). These individuals gave a past history of atopic 
dermatitis but, at the time of examination, displayed no or only minimal 
clinical activity such as mild xerosis and lichenified patches in the 
flexural areas. Five of the 14 patients reported the occurrence of asthma 
and allergic rhini tis in their past history. 
Normal control subjects (group III) with an age range from 14-48 yr 
(mean age: 28.3 ± 2.1 SEM) were nonatopic volunteer hospital and 
laboratory personnel. 
None of the individuals tested received systemic corticosteroids at 
least 6 mo or topical corticosteroids at least 4 days before being tested. 
All individuals were informed about the purpose of this study and 
consented to blood donation. ALI experiments described below were 
performed in all study groups (I-III) . ALI tests performed on a single 
individual were done on the same day. In addition, all procedures done 
on mononuclear cells from atopic dermatitis patients were performed 
in parallel with mononuclear ceLIs from a control person. 
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T Cell Enumeration (T- f ... !') 
Hepru'inized venous blood (20 U h eparin per ml of blood) was mixed 
with an equal volu me of Ca++ - and Mg++ -free Dulbecco's balanced salt 
solu tion (BSS) (Seromed Ges. m.b.H., Munich, Germany) and layered 
o n a Ficoll-Hypaque gradient (Lymphoprep, Nyegaard, Oslo, Norway). 
After centrifugation at 400 xg for 30 min at room temperature, the 
mononuclear laye r a t t he interface was carefully removed and washed 
3 t imes in BSS. Cells were then resuspended to a concentration of I X 
10"/ml RPMI 1640 (Seromed) supplemented with 20% heat-inactivated 
feta l calf serum (FCS) (Seromed) , 50 I-'g/ ml gentamicin (Schering Corp., 
K e nilworth, NJ, USA), 2 mM L-glu tamine (Grand Island Biologica l 
Corporation (GIBCO), Grand Island, NY, USA) ruld 20 mM Hepes 
buffer (GIBCO) . 10 1-'1 of 10% latex pru·ticles (1.1 I-'m, Dow Chemicals 
Co., Indianapolis, Ind. , USA) per I X 107 cells were then added and 
incubated with the cells for 1 hI'. (This step allows the labeling of 
phagocytic ce lls and permits cytophilic IgG to dissociate from the cells). 
After 3 washes in BSS, the ce LIs were resuspended to a concentra tion 
o f I X 107/ m!. 0. 1 ml of this cell suspension, 0.1 ml sheep red blood cell 
(SRBC)-ab orbed and heat-inactivated FCS and 0.2 ml of a 0.5% 
SRBC-suspension were mixed and incubated for 15 min at 37°C. After 
a 5- min centrifugation at 200 Xg the ce LIs were kept on ice for 18 hr. 
After gentle resuspension, at least 200 cells were coun ted and any 
ly mphocyte binding 3 or more SRBC was considered to be rosetted. 
T Cell PlIrifica.tion 
Peripheral mononucleru' cells as obtained by FicoLl -H ypaque sepa-
ra t lon were resuspended in medium 199 (Seromed) conta ining 20% FCS 
a nd plated on glass Petri dishes for I hI' a t 37°C in 5% CO2 atmo phere. 
N o nadherent ce lls were hru-vested, washed and mixed with neuramini-
dase-treated SRBC (EN) in a ratio of 1:100 in medium 199 supplemented 
wi th 25% SRBC-absorbed heat-inactivated FCS. This suspension was 
incubated a t 37°C for J5 min, spun at 200 g for 5 min and incubated for 
1 hI' on ice. T he cell mixture was then resuspended and layered on a 
Ficoll -Hypaque grad ient and the rosettes were pelleted a t 400 xg for 30 
min. T ce ll enrichment was considered satisfac tory if t he pelleted 
fraction conta ined, at least, 96% rosetted cells and 52% latex-ingesting 
a nd/ or non-specific esterase [19]-posit ive cells . If the purified T cell 
preparation did not meet these requirements, the sepru-ation procedure 
was repeated. Afte r lysing SRBC with ice-cold NH.,CI buffer purified T 
ce lls were washed with supplemen ted meclium 199 and resuspended to 
a concentra tion of 5 X IO';/ m!. 
D e tection of Fc- lgG and Fc- IgM Receptors on Purified T 
Lymphocytes 
a . Preparation of indicator cells: Bovine red blood cells (BRBC) 
stored in Alsever's solution were washed 3 times in Ca++- and Mg++-
fr ee BSS. A 5% BRBC suspension was sensitized with ant i-BRBC IgG 
frac tion (hemolytic titer 1:2500) , diluted 1/ 25 and a 2% BRBC-suspen-
s io n was sensit ized wi th anti -BRBC IgM fraction (hemolytic t iter I: 
8000) , diluted 1/ 4, by incubat ion at 37°C for 30 min. The IgG fraction 
was prepru'ed from a heal- inactivated rabbit immune serum by DEAE 
ion exchange chromatography, the IgM fraction by Sephadex G-200 gel 
c hromatography followed by Protein A immunoabsorpt ion. Purity was 
tested as described el,sewhere [20]. The antibody-coated BRBC (EA-
I gG and EA-IgM, respectively) were washed 3 times and resuspended 
in medium 199 to give a 1% suspension. 
b. Roselle assays: 100 1-'1 of the purified T cell population were mixed 
with 100 1-'1 EA-IgG , spun at 200 Xg for 5 min and incubated on ice for 
1-3 hI'. The pellet was then resuspended, a drop of the suspension was 
placed on a slide and 200 cells were counted. Any cell binding 3 or more 
r ed cells was considered to belong t.o the T y population (= Fc-IgG 
r ecepto r beru'ing T ce lls). Uncoated BHBC or BRBC coated with 
F(a b'h fragm ents of the ant ibody served as cont.rols. 
The remaining purified T cells were cultivated overnight at a con-
centration of 2 X 10'; cells/ml medium 199 supplemented with 20% 
h ea t-inactivated rcs, 50 I-'g/ ml gentamicin, 2 mM L-glutamine and 20 
mM Hepes buffer in a 5% COd 95% air-humidified a tmosphere. On the 
n ext day, ce lls were washed 3 times in medium 199 and resuspended (.0 
a concentration of 5 x IO';/ml. 100 ,tllymphocytes were mixed wi th 100 
/-ll of EA-lgM , cent rifuged for 5 min at 200 x g and incubated on ice for 
1-3 hI'S. After gentle resuspension, rosette formation was determined 
as desc ribed above. Rosetted ce LIs were considered to represent the 1'1-' 
popu lation (=Fc- IgM receptor bearing T ce LIs). 
L y mphocyte Stim.u lation by the Mitogen!; Con A and 
Phytohemagglut inin (PHA): 
Stock solutions of Con A (Pharmacia Fine Chern., Uppsa la, Sweden) 
or PHA (Wellcome Reagents Ltd. , Beckenham, England, UK) were 
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made from one pru-ticular batch, stored frozen at -70°C and thawed 
immediate ly before use throughout a ll experiments. Mononuclear cells 
obtained by Ficoll-Hypaque separa tion were adjusted to a concentra-
tion of 1 x 10'; ce Lls/ml RPM I ] 640 supplemented with 10% heat-
inactivated pooled human AB serum (GIBCO), 50 I-'g/ ml gentamicin, 2 
mM L-glu tamine and 20 mM Hepes. 5 X 10' ceLIs were cultured in the 
presence or absence of various Con A or PHA-concentrations for 72 hI' 
in a humidified 5% CO2/ 95% air atmosphere in round-bottomed micro-
t iter plates (Cooke Laboratory Products, Greiner, Niirtingen, FRG) in 
a to ta l volume of 0.2 ml/well. E ight hours before termination of the 
cul tul'e 25 I-'L (2 I-'Ci) of (methyl-aH)-thymidine (IH-TdR) specific 
activity 6.7 Ci/ mmol; (New England Nuclear Corp., Boston, Mass., 
USA) dilu ted in RPMI 1640 was then added to each well . 
Cul tures were harvested by t ransferring the contents of each well to 
glass fiber filt.ers via a multiple automated srunple harvester (Mash II 
Mic robiological Associates, Walkersville, Md., USA) and the am oun t 
of "H-thymidine incorporation was determined in a LKB Wallac 1215 
Rackbeta liquid scint illation counter . 
Suppressor Cell A ssay 
Experimental protocol: The suppressor T ceU assay was performed 
in a modifica tion of the methods described by several investigators [16-
18]: Penphera l blood mononuclear ceLIs were stimulat.ed with Con A to 
induce suppre sorT cells during a fU'st culture period. The abili ty of 
these Con A-activated cells (as compru'ed to precultured, nonactivated 
mononuclear cells ) to suppress mitogenic stimulation of autologous 
ce lls (in a few experiments a lso of a llogeneic cells) was then determined 
during a second cul ture. 
Con A Activation of Mononuclear Cells 
Mononuclear cells at a concentration of 1 x lO'i ml RPMI 1640 
(supplement.ed with 10% heat-inactivated pooled human AB serum, 50 
I-'g/ ml genta micin, 2 mM L-glu tamine and 20 mM Hepes buffer) were 
cul tured in 17 X 100 mm test tubes (Falcon P lastics, Oxnard, Ca ., USA) 
in either the presence or absence of Con A (12 I-'g/ ml fin al concent ra-
tion) in a humidilied atmosphere of 5% CO, and 95% air for 72 hr . After 
incubation, the cells were washed twice in RPMI 1640 conta ining 0.3 M 
a lpha-methyl-O-pyranoside (Sigma Corp. , St. Louis, Mo, USA) to 
ensure comple te removal of any Con A from the cells . After 2 additional 
washes in RPMI 1640, cells were resuspended to a concentration of 5 
x 10'; ce lls/ m!. They were then treated with mi tomycin C (Sigma) at a 
final concent ra tion of 25 I-'g/ml for 45 min at 37°C and, after extensive 
washing, they were resuspended to a concentration of 1 x 10(; ceUs/ml 
in supplemented RPMI 1640. 
Mitogen S timulation 
Fre h responder mononuclear ce lls (either autologous or a llogeneic 
to the precultured cells) were prepru'ed as described above and adjusted 
to a concent ration of I X 10H/ ml of supplemented RPMI 1640.0.05 ml 
of responder cells, 0 .05 ml of Con A-activated or control cells, and 0.05 
ml of either 36 I-'g/ ml Con A (= 12 I-'g/ ml final concentration) or 3 1-'g/ 
ml PHA (= 1 fLg/ ml fin al concentration) were dispensed in to sterile, 
round-bott.omed microli ter plates. Quadruplicate cultmes were incu-
bated for 72 hr in a humidified atmosphere of 5% CO2 and aiL DNA 
synthesis was then determined in a "H-thymidine incorporation assay 
as described above. The degTee of suppression was calculated according 
to the formula 
% suppression = (I -delta cpmCA / delta cpm NA ) X 100 
Delta cpm was calculated by subtracting mean cpm of unstimulat.ed 
cultures from mean cpm of stimula ted cul tures. Delta cpmCA is defined 
as delta cpm a fter the addition of Con A-activated cells to the second 
assay culture; delta cpm NA is delta cpm after the addition of incubated 
but nonactivated conb-ol cells to the second assay cu lture. 
Stati:;tics 
All valu es concerning th~ relative percentages of lymphocyte sub-
populations and percentages of suppression are expressed as a rithmetic 
mea ns ± standard error of the means (SEM) . Group comparisons for 
determinations of significance were performed using Student's t-test. 
Mitogen-induced lymphocyte proliferation data are expressed as the 
means of the logs of delta cpm values ± standa.rd deviation (SO) . 
RESULTS 
Lymphocyte S ubpopulations 
a. Total T cell counts (T-F.'[-): The percentage of T lympho-
cytes as determined by classical E rosette formation ranged in 
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group I from 58-78% (mean: 64.9 ± l.8) , in group II from 57-
74% (mean: 66.2 ± 1.5) and in group III from 69-87% (mean: 
77.3 ± 1.2) (Table I). The. differences between T -ET values of 
group I and II patients were statistically not significant, whereas 
statistically significant differences existed between T-n-levels 
from group III patients as compared to T- ET-levels from either 
group I or group II patients (p < 0.05) . 
b. T cell subpopulations as determined by differential 
expression of receptors for IgG and IgM (Table I) : In group I, 
Ty (rosette formation of purified T lymphocytes with EA-IgG) 
values ranged between 4- 11% (mean: 7.9 ± 0.6), in group II 
between 4-12% (mean: 8.2 ± 0.6) whereas in group III T y values 
between 14-21% (mean: 16.9 ± 0.6) were recorded. Differences 
in Ty values between groups I and II as compared to group III 
were statistically highly significant (p < 0.0005), whereas dif-
ferences between group I and group II values were not. The 
percentages of TIL values in all 3 study groups were largely 
identical, the minimal differences being not significant. 
Mitogen-Induced Lymphocyte Activation 
Mononuclear cells were incubated with varying concentra-
tions of the T cell mitogens Con A and PHA and the prolifer-
ative response was determined after 3 days of culture. A statis-
tical comparison of the data shown in Table II revealed no 
significant differences in the amount of T cell proliferation 
among the 3 study groups regardless of mitogen concentra tions. 
S uppressor Activity of Can A-activated T Cells for the 
Mitogenic R esponse of T Lymphocytes 
In t he first series of experiments, suppressor and responder 
cells were obtained from the sam e individual. Mononuclear 
cells which had been either pretreated with Con A or were 
untreated in a fust cultUl"e system, were mitomycin C-t reated 
and then added to test cultures containing freshly prepared 
autologous responder cells which were then stimulated with 
either Con A (4 ' Ilg/ml final concentration) or PHA (1 ,ug/ml 
final concentration). As shown in Figure A, Con A-activated T 
cells froin group III (normal) individuals consistently sup-
pressed the Con A-induced T cell stimulation in the second 
culture system, th e percentages of suppression ranging between 
12-90% (mean: 51.1 ± 5.5). In atopic dermatitis patients with 
either no or minimal clinical activity (group II), a similar degree 
of suppression was observed, the percentages of suppression 
ranging between 30-90.5% (mean: 56 ± 6.3). The difference 
between the degree of suppression in normal individuals com-
TABLE l. T lymphocylet;; and T lymphocyle subpopulations in severe 
and mild atopic dermatitis p atients and normal individuals 
No. Mean % posit ive ceUs ± SEM G roup" tested I. 
'T'-\<:T '1' ')'(' '1'1'" 
I Jl 64 .9 ± 1.8 7.9 ± 0.6 48.3 ± 1.3 
II 14 66.2 ± 1.5 8.2 ± 0.6 47. 1 ± 1.4 
III 18 77.3 ± 1.2 16.9 ± 0.6 46.8 ± 1.2 
" Group I-patients with severe disease activity . Group II-patients 
with mild disease activity. Group III- normal contro l individuals. 
"Percentage of posit ive ce lls in Ficoll-Hypaque prepared mononu -
clear cell preparat.ion discoun ting latex ingesting cells. 
,. Percentage of positive ceUs in EN rosette purified T cell population. 
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pared to group II atopic dermatitis patients was statistically not 
significant . In contrast, the ability of Con A-activated mono-
nuclear cells from patients with active atopic dermatitis to 
suppress Con A-induced stimulation of autologous responder 
cells was dramatically impaired (Figure A ). In only 3 patients 
from this group was the degree of suppression within the normal 
range, while in the other 8 patients, the T cell prolifera tion was 
only m inimally suppressed or even augmented. The mean per-
centage of suppression was 1.1 ± 11.2. This degree of suppres-
sion is significantly different from the results obtained in group 
II (p < 0.0005) and group III (p < 0.0005) patients. 
In order to assess the variation of the suppressor capacity of 
Con A-activated mononuclear cells wi thin single individuals at 
different t imes, several normal individuals were repeatedly 
tested. Results from a given individual, while showing some 
degree of varia tion, were consistently in the same range (data 
not shown). 
In order to assess the correlation of suppressor cell function 
a nd disease activity in the same individual, 2 patients included 
in group I were retested after successful topical treatment of 
their generalized eczematous eruption with cor t icosteroids. Be-
fore commencement of topical therapy, no suppression of the 
Con A response was seen (values 0% and 19% augmentation). 
The patients then received topical treatment until their skin 
lesions cleared. Topical treatment was then halted and the 
second tests of their suppressive capacities were performed 4 
days after the termination of topical treatment, but at a time 
when clinical symptoms had not yet reappeared. At this t ime, 
thei.r respective percentages of suppression had increased to 
74% a nd 56%. 
In contrast, the ab ility of Con A-activated T lymphocytes to 
suppress the mitogenic response to PHA was qu ite similar in 
the 3 groups tested . In normals (group III) , the mean percentage 
of suppression of the PHA-response was 16.8 ± 4.5, in group II 
patients 21.1 ± 4.7 and in group I patients 17.1 ± 4.9 (FigUl"e, 
B) . None of these differences proved to be significant. Regard-
ing the 2 group I patients mentioned in the preceding paragraph, 
successful treatment did not affect the abili ty of Con A-acti-
vated cells to suppress the PHA response. 
Cell Mixing Experiments 
From the preceding experiments we were not able to elucidate 
the mechanism underlying the defective suppression of the Con 
A-response in clinically active atopic dermatit is patients. In an 
attempt to determine whether the defect resides in the gener-
ation of suppressor cells or in the response to suppressor signals 
we performed cell mixing experiments using mononuclear cells 
from 2 patients wi t h severe disease and 2 normal individuals. 
For t hat purpose, we cocul tured mitomycin C-treated Con A-
activated mononuclear cells from normal individua ls wi th 
freshly prepared cells fTom clinically active atopic dermatitis 
patients and, in reverse fash ion, Con A-activated cells [Tom 
clinically active atopic dermatitis patients with freshly isolated 
cells from normal individuals . Resu lts of t hese experiments, 
which are listed in Table III, show that Con A-activated T cells 
from normals suppressed the patients' proliferative response as 
well as their own. By contrast, Con A-activated cells from these 
2 patients with active disease were impaired in their capacity to 
suppress the mitogenic responses of T cells from normal indi-
TABLE II. Comparison of lhe response to m.itogen- induced stim.ulation of m.ononuclear cellI; from mild and t;;evere atopic clennalitis patients 
and normal individuals 
Group'l No. t.ested 
12 
I 11 4.4 1 ± 0.35 
II l4 4.35±0.12 
III l8 4.29 ± 0.23 
Mean of logs "H-TdR cpm/5 X 10'\ cells ± SO 
Conca navalin A f1.g/ rnl 
4 
3.80 ± 0.57 3. 11 ± 0.52 
3.85 ± 0.41 3.28 ± 0.31 
3.85 ± 0.36 3.44 ± 0.22 
Phytohemagglu ti nin ll.g/ m J 
12 
4.G5 ± 0.26 
4.48 ± 0.26 
4.48 ± 0.32 
5.23 ± 0. 15 
5. l2 ± 0.2 1 
5. 13 ± 0.20 
" Group I-patients with severe disease activity. Group II-patients with mild disease activ ity. Group III - normal control ind ividua ls. 
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Dono r of' p recu l- Donor of' l'C- Experimen t I Ex pel'i ll1en l II 
l Ul'ed ce lls spo nri e l' cells De lta <.:pmN/\t/ Del tu cpm f 'A f!~ Su pprCti-')ioll lo D e lt a c pm :-l A De l!:l CPIll" A C( S upp ression 
N" N 17,3 J4 4,6 18 73 2H.()74 17,2():Z 42 
N A 2 1.179 8,450 60 19.1 04 12,035 37 
A' A 33.686 24 ,099 29 11 ,898 18,068 -34 
A N 12,3J4 10,242 17 9.7 11 10,396 -7 
" Delta cpm was calcula ted by sub tract ing mean cpm of unstimulated cultures from mean cpm of s t imula ted cul tures. Delt.a cpm( 'A is defi ned 
as delta cpm after the add ition of Con A-activated cells to the second assay culture; delta cpmN,\ is de lta cpm after the addition of incubated but 
nonactivated control ce lls to the second assay culture. 
" % suppression = ( I-delta cpm('''/delta cpm NA) X JOO; positive va lue indicates suppression, negative va lue indicates augmentation. 
,. Clinica lly active atopic dermatitis patient. 
d Normal individua l. 
viduals. These results suggest that the production of cells 
capable of exerting suppressor signals rather than the response 
to s uch signals is defi cient in clinically active atopic dermatit is 
patients . 
DISCUSSION 
T he clinical evidence of impaired cell-mediated immuni ty in 
atopic dermati tis patients is only partly suppor ted by in vitro 
studies. Whereas some authors observed low lymphocyte re-
sponses to PHA [2,11 ,21-23], others found the response to be 
not significantly different from that of normals [24-27]. S imilar 
discrepancies ar e reported with concern to the Con A 
[ 22,23,26,28,29] or pokeweed-mitogen (PWM) response 
[ 22,23,26]. Though reports exist indicating t hat al tered mito-
genic reactivity in atopic dermatitis patients is dependent on 
t h e severi ty of the clinical disease, our findings do not support 
this suggestion since we did not find obvious differences in the 
T cell proliferative response to Con A or PHA between severe 
atopies and normal individuals. It is difficult, however, to com-
pare the results obtained in various studies (including our own) 
regarding the response of l' cells from atopies to mitogenic 
stimulation since the culture conditions and mitogen-concen-
trations employed vary greatly. 
Many authors agree that l' lymphocytes-as measured by 
t heir ability to form nonimmune rosettes with SRBC- are 
reduced in number in atopic dermatit is patients [22-
24,26,27,30-33], but cont roversy exists as to whether these 
red uced l' cell numbers parallel the extent of clinical disease 
[23,26,27]' Several other studies, however, did not reveal a 
signifi cant l' cell lymphopenia in these patients [25,34,35]. Our 
results confirm the fonner reports on significantly lowered l' 
celJ values in atopic dermatitis patients, and in our experience, 
this l' cell lymphopenia was a consistent finding independent 
of the clinical status of the patient. On the basis of our results, 
it appears to be likely that t he decreased l' cell numbers in 
atopic dermatitis patient.s are due to a subpopulation-specific l' 
celJ deficiency. We found ' in these pat.ients a pronounced nu-
merical reduction in l' cells bearing Fc-IgG receptors (Ty cells) 
whereas TJl cell (1' cells bearing Fc-IgM receptors) values wer e 
within the normal range. 
In contrast to a most recent repor t by Schuster et al [36] 
describing a Ty cell defi cit in atopic dermatitis patients reflect-
ing disease activity, we found the reduction in T y cell numbers 
to be very consistent regardless of the extent of the eczematous 
erupt ion. In view of a recent report by Canonica et a l [37] 
describing decreased Ty values in patients with allergic rhini tis 
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a nd/ or asthma, it is conceivable that reduced Ty cell numbers 
are a n intrins ic characteristic of atopic individuals. We feel that 
it is unlik ely that this Ty cell deficit is a manifestation of either 
in vivo modulation of Fc-IgG receptors by immune complexes 
or a " homing" of these cells in the skin since atopic dermatitis 
patients have not been shown to have circulating immune 
complexes a nd ex hibit decreased T y cell values independent of 
disease activity. 
Co nside ring the functional role ofTy cells in immune respon-
siveness, our findings may provide insight into some pathoge-
netic mechanisms operative in atopic dermatitis. Ty cells me-
diate natural cytotoxicity and antibody-dependent cellular cy-
totoxicity [38] a nd, in addition, exert suppressive effects on 
PWM-induced polyclonal B cell activation [13-15]. 
While formal evidence is lacking, one may speculate that a 
di.rect re lationship exists between the Ty cell deficit and the 
hyperimm'lmoglobulinemia E frequently observed in atopic der-
matitis patients. It seems evident that IgE antibody synthesis 
is not only controlled by a ntigen-specific r egulatory T lympho-
cytes [39,40] but also by a nonspecific suppressor mechanism 
that appears to act rather selectively on antibody responses of 
the IgE class [41]. It is conceivable tha t Ty cells participate in 
this "d a mping mechanism" and that a Ty cell deficiency results 
in e levated IgE levels. 
A word of caution is warranted at this point. The T cell 
nature of t he T y ce ll has been challenged by a recent study 
from Reinherz et al [42]. These authors utilized a series of 
monoclonal a ntibodies reactive with T cells, monocytes a nd Ia 
a ntigens for further characteriza tion of Ty and T/l cells . 
Whereas t he T cell antigen OKT 3 was expressed on virtually 
a ll T/l cells, it was only present on a subpopulation of Ty cells. 
Residual Ty cells by contrast, possessed t he monocyte antigen 
OKM 1. One might therefore argue that a considerable portion 
of so-call ed Ty cells is of monocytic rather than T lymphocytic 
lineage a nd that the defect observed in atopic dermatitis pa-
t ients resides at t he level of the monocyte rather than at the 
level of t he T lymphocyte. However, the finding that monocytes 
a nd a . Ty cell subpopulation share in common a particular 
a n t ige nic determinant is not sufficient proof that these cells are 
of t he sam e lineage. Certainly, Ty cells do not qualify as typical 
m ononuclear phagocytes s ince the numbe r of esterase-positive, 
latex-ingesting cells in our purified population of E w rosetted 
cells never exceeded 2%, a number far below that of Fc-IgG 
receptor bearing cells in this popula tion. 
While a pronounced Ty cell r eduction was observed in both 
clinically active and clinically silent patients, the ability to 
generate Con A-induced suppressor cells was clearly dependent 
on diseal3e activity and was shown to vary in 2 individual 
patients according to their clinical status. These findings sug-
gest t hat t he impaire d generation of suppressor cells in clinically 
active atopic dermatitis patients does not represent a primary 
phenomenon in the pathogenesis of atopic disease. In this 
rega rd , it is of interest to note that Martinez et al [43] observed 
no differences in Con A-induced suppressor cell function be-
tween nonallergic individuals and atopic patients suffering from 
allergic rhini t is and/or asthma but not from atopic dermatitis . 
The reasons for the impaired generation of suppressor cells in 
clinically active atopic derma titis patients remains to be clari-
fi ed. One hypothesis to expla in this phenomenon may stem 
fTom the observation that lymphocytes from atopic individuals 
are unusually sensitive to histamine-induced, cyclic adenosine 
mO;lOphosphate (cAMP)-mediated, functional impairment 
[44,45]. Histamine released following the interaction of mast 
cell -bound IgE and a re levant antigen may possibly exert ad-
verse influences on the suppressor cell precursor population in 
atopic patients resulting in a further imbalance of regulatory 
cells and, thus perhaps culminating in effector cell dysfunction. 
Though highly spec ulative, another explanation may be that in 
atopic individuals experiencing eczematous flaring, suppressor 
cell precursors may lodge in the skin accounting for a reduction 
of these cells in the circulation . 
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